Leyden Labs

Developer of nasal sprays containing antibodies targeting respiratory viruses in the nasal mucosa

placeAmsterdam, North Holland, Netherlands calendar_todayFounded 2020 groups80 employees language leydenlabs.com

Social engagement

Social engagement: 9.2K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

13 investors on record; lead investors include Google Ventures, Casdin Capital, Clavystbio, Polaris Partners.

Investor typeCountShare
Venture capital969%
Private equity215%
Other / undisclosed215%

Recent activity

18 Jun 2026
Event
BIO International Convention 2026
2 Jun 2026
Event
Jefferies Global Healthcare Conference
Coming soon